Three Undervalued Stocks Worth Considering

As the U.S. presidential election fast approaches, investor anxieties are reaching a fever pitch like an orchestra building up to a crescendo. In such times of market tumult, seeking refuge in defensive dividend stocks can be akin to finding a sturdy lifeboat in a stormy sea.

Among the entities that stand out in this defensive arena is Zoetis Inc., a stalwart player in the realm of animal health. With a legacy spanning over seven decades, Zoetis has become a beacon of stability in a sea of market fickleness, akin to a lighthouse guiding ships through rough waters.

Despite a YTD dip of 4%, Zoetis has clung tenaciously to its pillars of stability amidst the tumultuous market winds. The company's market cap looms large at around $85.1 billion, offering an anchor of steadfastness when the market tides turn rough.

Zoetis' five-year streak of consecutive dividend increases speaks volumes about its resilience. The company sails ahead, paying out a quarterly dividend of $0.432 per share with an annualized dividend of $1.73 per share.

In August, Zoetis made waves as it surpassed all expectations with its second-quarter earnings. Like an eagle soaring high above the clouds, the company posted a revenue of $2.4 billion, signaling an 8% rise from the previous year—a testament to its unyielding spirit in the face of adversity.

Guided by CEO Kristin Peck's steady hand, Zoetis raised its fiscal 2024 guidance with the confidence of a sure-footed mountaineer conquering new heights. The company anticipates revenue growth between $9.10 billion and $9.25 billion, paving the way for a brighter future.

With a resounding consensus of "Strong Buy" ratings from analysts, Zoetis stands as a paragon of excellence in the eyes of the market. The price targets put forth a promising future, with a potential upside of 15.7% from current levels.

Turning our gaze to another bastion of stability, Kenvue Inc. emerges as a formidable contender in the landscape of consumer health, a shield repelling the arrows of uncertain market forces.

With a rich heritage dating back over a century, Kenvue boasts a diversified portfolio of trusted brands, standing strong with a market cap of $43.1 billion. The stock has surged 23% in the past three months, outshining broader market indices like a gleaming beacon in the night sky.

Kenvue's recent dividend increase underscores its unwavering commitment to shareholders, offering $0.205 per share and a hearty 3.64% yield. This move aligns with the company's endeavor to drive sustainable growth and provide a steady hand amid market turmoil.